2021 ESG Report Healthy People Making Healthier Happen for Millions The future of kidney care progression of the disease. We do 2021, CVS Health announced a Treatment for chronic kidney this by reaching patients where they partnership between Coram®, our in- disease (CKD) and end stage renal are, promoting in-home dialysis home infusion business, and Cancer disease (ESRD) can be challenging and partnering with CVS Health’s Treatment Centers of America and costly for patients and their community-based resources, such (CTCA) to deliver chemotherapy families, especially in Black and as HealthHUBs. treatment to patients in the safety Hispanic communities — as well and comfort of home. Visits from as for the health care system. In-home chemotherapy a Coram nurse to administer CVS Kidney Care®, a CVS Health For immunocompromised cancer the therapy can be paired with company, embraces a new patients in chemotherapy, the telehealth and digital check-ins approach focused on early COVID-19 pandemic presented with CTCA care team members, identification of kidney disease, a heightened risk of exposure to allowing patients with a range of targeted patient engagement and the virus when seeking inpatient cancers to safely continue their ongoing education to help slow the or in-office treatment. In January critical cancer care. 18
ESG Report | CVS Health Page 17 Page 19